CN Stock MarketDetailed Quotes

301015 Qingdao Baheal Medical INC.

Watchlist
  • 28.55
  • -0.14-0.49%
Market Closed Nov 6 15:00 CST
15.01BMarket Cap19.97P/E (TTM)

Qingdao Baheal Medical INC. Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Assets
Current assets
Money funds
26.01%1.27B
37.96%1.9B
31.94%1.51B
28.32%1.34B
0.88%1.01B
52.69%1.38B
-3.58%1.15B
-17.91%1.05B
-22.46%999.7M
-27.12%901.51M
Transactional financial assets
692.92%183.38M
2.80%25.21M
25.40%27.13M
1.45%27.62M
-29.90%23.13M
45.27%24.52M
-25.53%21.63M
-33.23%27.22M
-13.09%32.99M
-62.08%16.88M
Notes receivable and accounts receivable
-0.13%2.29B
1.50%2.15B
12.53%2.18B
11.22%2.37B
17.09%2.29B
3.02%2.12B
-7.90%1.94B
12.07%2.13B
0.02%1.96B
17.74%2.05B
-Notes receivable
-24.45%101.89M
3.11%137.5M
138.89%230.6M
83.90%182.89M
239.55%134.87M
249.44%133.35M
138.65%96.53M
141.97%99.45M
--39.72M
--38.16M
-Accounts receivable
1.39%2.19B
1.40%2.01B
5.91%1.95B
7.66%2.18B
12.49%2.16B
-1.64%1.98B
-10.77%1.84B
9.19%2.03B
-2.01%1.92B
15.55%2.02B
Other receivables (including interest and dividends)
11.11%53.22M
-19.57%35.6M
-26.57%34.64M
383.35%214.78M
-4.70%47.89M
-5.54%44.27M
34.00%47.17M
7.50%44.43M
-3.65%50.26M
3.85%46.86M
-Accrued interest receivable
--3.03M
----
----
----
----
----
----
----
----
----
-Other receivable
----
-19.57%35.6M
----
----
----
-5.54%44.27M
----
8.01%44.43M
----
9.79%46.86M
Contractual assets
----
----
----
----
----
--0
----
----
----
--0
Advance payment
-0.36%279.65M
-11.42%202.62M
6.16%220.13M
-26.03%182.43M
49.32%280.66M
0.03%228.74M
35.27%207.35M
54.06%246.64M
22.53%187.96M
68.53%228.67M
Inventories
37.84%880.27M
-4.54%613.66M
-9.93%661.32M
32.55%861.67M
-12.84%638.63M
10.99%642.83M
20.49%734.25M
4.21%650.1M
26.60%732.75M
-4.08%579.17M
Receivable financing
184.88%382.02M
89.91%207.42M
-30.41%133.9M
-6.83%97.55M
-11.63%134.1M
154.27%109.22M
381.83%192.41M
135.49%104.7M
70.21%151.75M
-53.46%42.95M
Assets held for sale
----
----
----
----
----
--0
----
----
----
--0
Non-current assets due within one year
----
----
----
----
----
--0
----
----
----
--0
Other current assets
145.48%30.81M
23.75%17.69M
56.43%19.47M
149.06%23.51M
194.10%12.55M
210.82%14.29M
181.74%12.45M
48.22%9.44M
-76.81%4.27M
-70.32%4.6M
Total current assets
20.99%5.37B
13.01%5.15B
11.40%4.79B
20.21%5.12B
7.78%4.44B
17.60%4.56B
3.24%4.3B
4.06%4.26B
-1.53%4.12B
-1.12%3.87B
Non Current assets
Other equity investment
--39.35M
--24.42M
--24.5M
--24.5M
----
--0
----
----
----
-0.38%7.17M
Other non-current financial assets
----
----
----
----
----
--0
----
----
----
----
Investment real estate
-97.49%1.35M
-97.47%1.38M
-97.45%1.4M
-97.44%1.43M
-4.27%53.81M
-4.23%54.41M
-4.18%55.01M
-4.14%55.61M
-5.45%56.21M
-5.30%56.81M
Long-term equity investment
28.57%323.5M
14.62%281.81M
36.96%247.93M
31.88%239.45M
51.77%251.6M
61.24%245.87M
20.71%181.02M
25.62%181.57M
21.26%165.78M
16.68%152.49M
Fixed assets
----
17.68%211.24M
----
----
----
0.75%179.5M
----
0.22%178.33M
----
3.02%178.17M
Constru in process
----
15.39%105.69M
----
----
----
356.52%91.6M
----
816.41%80.5M
----
--20.06M
Productive biological assets
----
----
----
----
----
--0
----
----
----
----
Oil and gas assets
----
----
----
----
----
--0
----
----
----
----
Intangible assets
145.42%138.54M
67.25%98.36M
84.45%101.54M
146.78%140.09M
55.31%56.45M
50.96%58.81M
88.12%55.05M
98.15%56.77M
23.77%36.35M
33.00%38.96M
Development expenditure
----
----
----
----
----
--0
----
----
----
--12.27K
Goodwill
15,386.70%107.6M
0.00%694.76K
0.00%694.76K
15,386.70%107.6M
0.00%694.76K
-88.35%694.76K
-88.35%694.76K
-88.35%694.76K
-88.35%694.76K
0.00%5.96M
Long deferred expense
67.67%35.99M
61.26%32.06M
382.49%33.27M
328.52%34.31M
68.26%21.46M
100.77%19.88M
8.74%6.9M
-3.52%8.01M
28.17%12.76M
32.98%9.9M
Deferred tax assets
46.81%63.35M
25.77%48.89M
17.38%48.3M
108.94%76.57M
28.40%43.15M
21.69%38.87M
22.98%41.14M
11.57%36.65M
-7.56%33.61M
-20.07%31.94M
Usufruct assets
-39.99%126.43M
-37.48%102.11M
-42.77%97.18M
-37.95%108.07M
8.33%210.69M
-6.80%163.31M
334.41%169.82M
346.21%174.16M
357.52%194.49M
231.61%175.23M
Other non current assets
--4.33M
----
----
--3.07M
----
--0
----
----
----
--0
Total non current assets
64.89%1.53B
6.30%906.66M
9.45%855.9M
68.22%1.3B
26.29%925.13M
26.04%852.95M
51.48%781.99M
51.06%772.29M
45.29%732.53M
33.65%676.72M
Total assets
28.56%6.9B
11.95%6.06B
11.10%5.65B
27.58%6.42B
10.58%5.36B
18.85%5.41B
8.56%5.08B
9.28%5.03B
3.50%4.85B
2.86%4.55B
Liabilities
Current liabilities
Short term loan
101.00%958.28M
53.67%1.33B
-33.99%764.15M
-55.96%513.02M
-57.65%476.77M
-20.34%865.78M
-6.35%1.16B
-1.99%1.17B
-12.21%1.13B
-12.30%1.09B
Transactional financial liabilities
----
----
----
----
----
--0
----
----
----
--0
Notes payable and accounts payable
27.83%1.25B
-3.21%906.31M
-16.83%843.11M
8.24%1.07B
-8.40%979.56M
2.10%936.39M
20.69%1.01B
17.09%990.3M
16.04%1.07B
7.99%917.11M
-Notes payable
11.36%407.39M
-6.02%301.24M
-32.52%279.73M
-15.19%330.09M
-14.89%365.82M
-5.00%320.54M
75.21%414.55M
71.21%389.24M
230.42%429.81M
159.55%337.42M
-Accounts payable
37.65%844.82M
-1.75%605.07M
-5.97%563.38M
23.41%741.78M
-4.03%613.73M
6.24%615.85M
-0.69%599.14M
-2.81%601.06M
-19.19%639.52M
-19.40%579.69M
Contract liabilities
-32.28%80.92M
-32.72%82.14M
14.03%115.11M
5.76%97.8M
38.22%119.49M
58.01%122.08M
34.73%100.94M
-18.72%92.48M
21.35%86.45M
9.89%77.26M
Advance receipts
----
----
----
----
----
--0
----
--0
----
--0
Salaries payable
6.54%81.95M
4.82%70.19M
18.86%54.79M
20.92%114.74M
34.69%76.92M
28.08%66.96M
9.13%46.1M
27.44%94.89M
13.20%57.11M
13.79%52.28M
Taxs payable
43.06%162.86M
26.49%103.87M
23.16%83.85M
40.77%126.93M
8.50%113.84M
-5.10%82.12M
3.07%68.08M
47.70%90.17M
17.53%104.92M
29.53%86.53M
Other payable (including interest and dividends)
488.45%510.7M
-32.68%59.89M
-25.50%68.32M
285.23%355.03M
8.98%86.79M
-17.33%88.96M
-16.60%91.7M
6.08%92.16M
41.28%79.64M
92.62%107.61M
-Dividend payable
----
----
----
----
----
----
--980K
----
----
----
-Other payable
----
-32.68%59.89M
----
----
----
-17.33%88.96M
----
6.08%92.16M
----
92.62%107.61M
Non current liabilities due within one year
69.01%58.77M
-30.00%19.29M
-24.51%19.81M
200.74%82.22M
10.78%34.77M
-13.89%27.56M
43.40%26.24M
77.33%27.34M
54.89%31.39M
68.15%32.01M
Other current liabilities
-18.61%29.54M
-53.62%19.6M
39.52%47.33M
-41.83%29.93M
195.75%36.29M
267.95%42.25M
221.30%33.92M
249.63%51.44M
34.38%12.27M
-3.35%11.48M
Total current liabilities
62.92%3.14B
16.11%2.59B
-21.35%2B
-8.15%2.39B
-25.03%1.92B
-5.86%2.23B
5.85%2.54B
8.46%2.6B
2.65%2.57B
0.54%2.37B
Current liabilities
Long term loan
--342.81M
----
----
--45.66M
----
----
----
----
----
----
Bonds payable
2.33%747.73M
2.38%740.54M
--733.42M
--726.26M
--730.71M
--723.3M
----
----
----
----
Preferred stock
----
----
----
----
----
--0
----
----
----
----
Perpetual Debt
----
----
----
----
----
--0
----
----
----
----
Long term salaries pay
----
----
----
----
----
--0
----
----
----
----
Estimate liabilities
----
----
----
----
----
--0
----
----
----
----
Deferred tax liabilities
7,662.54%34M
681.79%24.56M
1,894.43%26.84M
1,786.73%33.54M
-54.55%437.99K
3.64%3.14M
-57.69%1.35M
-69.61%1.78M
-81.84%963.58K
-57.26%3.03M
Long term deferred income
--12M
----
----
--13.6M
----
--0
----
----
----
----
Lease liabilities
-41.40%109.43M
-36.10%91.73M
-42.58%84.19M
-39.86%87.41M
17.46%186.73M
5.04%143.54M
664.76%146.62M
554.39%145.34M
535.45%158.98M
339.37%136.65M
Other non current liabilities
----
----
----
----
----
--0
----
----
----
----
Total non current liabilities
35.74%1.25B
-1.51%856.83M
470.71%844.45M
516.16%906.47M
473.88%917.88M
522.82%869.98M
561.97%147.96M
424.28%147.12M
427.46%159.94M
265.74%139.68M
Total liabilities
54.14%4.38B
11.17%3.45B
5.76%2.84B
19.89%3.3B
4.23%2.84B
23.55%3.1B
10.98%2.69B
13.26%2.75B
7.74%2.73B
4.77%2.51B
Shareholders equity
Paid-in capital
0.10%525.61M
0.10%525.61M
0.10%525.61M
0.10%525.61M
0.00%525.1M
0.00%525.1M
0.00%525.1M
0.00%525.1M
0.00%525.1M
0.00%525.1M
Other equity instruments
-26.20%99.77M
-26.20%99.77M
--99.77M
--99.78M
--135.2M
--135.2M
----
----
----
----
-Equity of prefer stock
----
----
----
----
----
--0
----
----
----
----
-Equity of Perpetual debt
----
----
----
----
----
--0
----
----
----
----
Capital reserve funds
----
2.46%421.74M
2.26%421.74M
63.31%672.19M
2.79%423.79M
-0.19%411.61M
-0.89%412.44M
-1.60%411.61M
-17.25%412.3M
-17.26%412.37M
Surplus reserve funds
-24.24%109.04M
18.51%170.56M
18.51%170.56M
18.51%170.56M
8.63%143.93M
8.63%143.93M
8.63%143.93M
8.63%143.92M
42.26%132.49M
42.26%132.49M
Retained profit
19.96%1.58B
26.33%1.42B
20.35%1.61B
20.92%1.47B
22.34%1.31B
18.85%1.12B
14.79%1.34B
12.98%1.22B
6.76%1.07B
6.71%943.89M
Less:Treasury stock
----
----
----
----
----
--0
----
----
----
----
Other composite income
-83.26%309.08K
-62.24%685.94K
94.85%1.67M
12.51%1.86M
194.05%1.85M
-16.14%1.82M
-60.45%858.06K
-21.92%1.65M
-49.29%627.84K
100.86%2.17M
Ordinary risk reserve funds
----
----
----
----
----
--0
----
----
----
----
Specific reserves
----
----
----
--2.25M
----
--0
----
----
----
----
Shareholders equity without minority interests
-9.16%2.31B
12.66%2.64B
16.92%2.83B
28.03%2.95B
18.62%2.54B
16.04%2.34B
7.99%2.42B
6.69%2.3B
0.98%2.14B
0.69%2.02B
Minority interests
1,066.91%204.84M
11.68%-28.8M
-1.78%-27.17M
869.47%172.61M
-7.08%-21.19M
-235.53%-32.61M
-250.42%-26.7M
-233.87%-22.43M
-160.39%-19.78M
-5.61%24.06M
Total shareholder equity
-0.27%2.52B
13.00%2.61B
17.09%2.81B
36.86%3.12B
18.72%2.52B
13.07%2.31B
5.96%2.4B
4.84%2.28B
-1.47%2.12B
0.61%2.04B
Total liabilityies and equity
28.56%6.9B
11.95%6.06B
11.10%5.65B
27.58%6.42B
10.58%5.36B
18.85%5.41B
8.56%5.08B
9.28%5.03B
3.50%4.85B
2.86%4.55B
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Assets
Current assets
Money funds 26.01%1.27B37.96%1.9B31.94%1.51B28.32%1.34B0.88%1.01B52.69%1.38B-3.58%1.15B-17.91%1.05B-22.46%999.7M-27.12%901.51M
Transactional financial assets 692.92%183.38M2.80%25.21M25.40%27.13M1.45%27.62M-29.90%23.13M45.27%24.52M-25.53%21.63M-33.23%27.22M-13.09%32.99M-62.08%16.88M
Notes receivable and accounts receivable -0.13%2.29B1.50%2.15B12.53%2.18B11.22%2.37B17.09%2.29B3.02%2.12B-7.90%1.94B12.07%2.13B0.02%1.96B17.74%2.05B
-Notes receivable -24.45%101.89M3.11%137.5M138.89%230.6M83.90%182.89M239.55%134.87M249.44%133.35M138.65%96.53M141.97%99.45M--39.72M--38.16M
-Accounts receivable 1.39%2.19B1.40%2.01B5.91%1.95B7.66%2.18B12.49%2.16B-1.64%1.98B-10.77%1.84B9.19%2.03B-2.01%1.92B15.55%2.02B
Other receivables (including interest and dividends) 11.11%53.22M-19.57%35.6M-26.57%34.64M383.35%214.78M-4.70%47.89M-5.54%44.27M34.00%47.17M7.50%44.43M-3.65%50.26M3.85%46.86M
-Accrued interest receivable --3.03M------------------------------------
-Other receivable -----19.57%35.6M-------------5.54%44.27M----8.01%44.43M----9.79%46.86M
Contractual assets ----------------------0--------------0
Advance payment -0.36%279.65M-11.42%202.62M6.16%220.13M-26.03%182.43M49.32%280.66M0.03%228.74M35.27%207.35M54.06%246.64M22.53%187.96M68.53%228.67M
Inventories 37.84%880.27M-4.54%613.66M-9.93%661.32M32.55%861.67M-12.84%638.63M10.99%642.83M20.49%734.25M4.21%650.1M26.60%732.75M-4.08%579.17M
Receivable financing 184.88%382.02M89.91%207.42M-30.41%133.9M-6.83%97.55M-11.63%134.1M154.27%109.22M381.83%192.41M135.49%104.7M70.21%151.75M-53.46%42.95M
Assets held for sale ----------------------0--------------0
Non-current assets due within one year ----------------------0--------------0
Other current assets 145.48%30.81M23.75%17.69M56.43%19.47M149.06%23.51M194.10%12.55M210.82%14.29M181.74%12.45M48.22%9.44M-76.81%4.27M-70.32%4.6M
Total current assets 20.99%5.37B13.01%5.15B11.40%4.79B20.21%5.12B7.78%4.44B17.60%4.56B3.24%4.3B4.06%4.26B-1.53%4.12B-1.12%3.87B
Non Current assets
Other equity investment --39.35M--24.42M--24.5M--24.5M------0-------------0.38%7.17M
Other non-current financial assets ----------------------0----------------
Investment real estate -97.49%1.35M-97.47%1.38M-97.45%1.4M-97.44%1.43M-4.27%53.81M-4.23%54.41M-4.18%55.01M-4.14%55.61M-5.45%56.21M-5.30%56.81M
Long-term equity investment 28.57%323.5M14.62%281.81M36.96%247.93M31.88%239.45M51.77%251.6M61.24%245.87M20.71%181.02M25.62%181.57M21.26%165.78M16.68%152.49M
Fixed assets ----17.68%211.24M------------0.75%179.5M----0.22%178.33M----3.02%178.17M
Constru in process ----15.39%105.69M------------356.52%91.6M----816.41%80.5M------20.06M
Productive biological assets ----------------------0----------------
Oil and gas assets ----------------------0----------------
Intangible assets 145.42%138.54M67.25%98.36M84.45%101.54M146.78%140.09M55.31%56.45M50.96%58.81M88.12%55.05M98.15%56.77M23.77%36.35M33.00%38.96M
Development expenditure ----------------------0--------------12.27K
Goodwill 15,386.70%107.6M0.00%694.76K0.00%694.76K15,386.70%107.6M0.00%694.76K-88.35%694.76K-88.35%694.76K-88.35%694.76K-88.35%694.76K0.00%5.96M
Long deferred expense 67.67%35.99M61.26%32.06M382.49%33.27M328.52%34.31M68.26%21.46M100.77%19.88M8.74%6.9M-3.52%8.01M28.17%12.76M32.98%9.9M
Deferred tax assets 46.81%63.35M25.77%48.89M17.38%48.3M108.94%76.57M28.40%43.15M21.69%38.87M22.98%41.14M11.57%36.65M-7.56%33.61M-20.07%31.94M
Usufruct assets -39.99%126.43M-37.48%102.11M-42.77%97.18M-37.95%108.07M8.33%210.69M-6.80%163.31M334.41%169.82M346.21%174.16M357.52%194.49M231.61%175.23M
Other non current assets --4.33M----------3.07M------0--------------0
Total non current assets 64.89%1.53B6.30%906.66M9.45%855.9M68.22%1.3B26.29%925.13M26.04%852.95M51.48%781.99M51.06%772.29M45.29%732.53M33.65%676.72M
Total assets 28.56%6.9B11.95%6.06B11.10%5.65B27.58%6.42B10.58%5.36B18.85%5.41B8.56%5.08B9.28%5.03B3.50%4.85B2.86%4.55B
Liabilities
Current liabilities
Short term loan 101.00%958.28M53.67%1.33B-33.99%764.15M-55.96%513.02M-57.65%476.77M-20.34%865.78M-6.35%1.16B-1.99%1.17B-12.21%1.13B-12.30%1.09B
Transactional financial liabilities ----------------------0--------------0
Notes payable and accounts payable 27.83%1.25B-3.21%906.31M-16.83%843.11M8.24%1.07B-8.40%979.56M2.10%936.39M20.69%1.01B17.09%990.3M16.04%1.07B7.99%917.11M
-Notes payable 11.36%407.39M-6.02%301.24M-32.52%279.73M-15.19%330.09M-14.89%365.82M-5.00%320.54M75.21%414.55M71.21%389.24M230.42%429.81M159.55%337.42M
-Accounts payable 37.65%844.82M-1.75%605.07M-5.97%563.38M23.41%741.78M-4.03%613.73M6.24%615.85M-0.69%599.14M-2.81%601.06M-19.19%639.52M-19.40%579.69M
Contract liabilities -32.28%80.92M-32.72%82.14M14.03%115.11M5.76%97.8M38.22%119.49M58.01%122.08M34.73%100.94M-18.72%92.48M21.35%86.45M9.89%77.26M
Advance receipts ----------------------0------0------0
Salaries payable 6.54%81.95M4.82%70.19M18.86%54.79M20.92%114.74M34.69%76.92M28.08%66.96M9.13%46.1M27.44%94.89M13.20%57.11M13.79%52.28M
Taxs payable 43.06%162.86M26.49%103.87M23.16%83.85M40.77%126.93M8.50%113.84M-5.10%82.12M3.07%68.08M47.70%90.17M17.53%104.92M29.53%86.53M
Other payable (including interest and dividends) 488.45%510.7M-32.68%59.89M-25.50%68.32M285.23%355.03M8.98%86.79M-17.33%88.96M-16.60%91.7M6.08%92.16M41.28%79.64M92.62%107.61M
-Dividend payable --------------------------980K------------
-Other payable -----32.68%59.89M-------------17.33%88.96M----6.08%92.16M----92.62%107.61M
Non current liabilities due within one year 69.01%58.77M-30.00%19.29M-24.51%19.81M200.74%82.22M10.78%34.77M-13.89%27.56M43.40%26.24M77.33%27.34M54.89%31.39M68.15%32.01M
Other current liabilities -18.61%29.54M-53.62%19.6M39.52%47.33M-41.83%29.93M195.75%36.29M267.95%42.25M221.30%33.92M249.63%51.44M34.38%12.27M-3.35%11.48M
Total current liabilities 62.92%3.14B16.11%2.59B-21.35%2B-8.15%2.39B-25.03%1.92B-5.86%2.23B5.85%2.54B8.46%2.6B2.65%2.57B0.54%2.37B
Current liabilities
Long term loan --342.81M----------45.66M------------------------
Bonds payable 2.33%747.73M2.38%740.54M--733.42M--726.26M--730.71M--723.3M----------------
Preferred stock ----------------------0----------------
Perpetual Debt ----------------------0----------------
Long term salaries pay ----------------------0----------------
Estimate liabilities ----------------------0----------------
Deferred tax liabilities 7,662.54%34M681.79%24.56M1,894.43%26.84M1,786.73%33.54M-54.55%437.99K3.64%3.14M-57.69%1.35M-69.61%1.78M-81.84%963.58K-57.26%3.03M
Long term deferred income --12M----------13.6M------0----------------
Lease liabilities -41.40%109.43M-36.10%91.73M-42.58%84.19M-39.86%87.41M17.46%186.73M5.04%143.54M664.76%146.62M554.39%145.34M535.45%158.98M339.37%136.65M
Other non current liabilities ----------------------0----------------
Total non current liabilities 35.74%1.25B-1.51%856.83M470.71%844.45M516.16%906.47M473.88%917.88M522.82%869.98M561.97%147.96M424.28%147.12M427.46%159.94M265.74%139.68M
Total liabilities 54.14%4.38B11.17%3.45B5.76%2.84B19.89%3.3B4.23%2.84B23.55%3.1B10.98%2.69B13.26%2.75B7.74%2.73B4.77%2.51B
Shareholders equity
Paid-in capital 0.10%525.61M0.10%525.61M0.10%525.61M0.10%525.61M0.00%525.1M0.00%525.1M0.00%525.1M0.00%525.1M0.00%525.1M0.00%525.1M
Other equity instruments -26.20%99.77M-26.20%99.77M--99.77M--99.78M--135.2M--135.2M----------------
-Equity of prefer stock ----------------------0----------------
-Equity of Perpetual debt ----------------------0----------------
Capital reserve funds ----2.46%421.74M2.26%421.74M63.31%672.19M2.79%423.79M-0.19%411.61M-0.89%412.44M-1.60%411.61M-17.25%412.3M-17.26%412.37M
Surplus reserve funds -24.24%109.04M18.51%170.56M18.51%170.56M18.51%170.56M8.63%143.93M8.63%143.93M8.63%143.93M8.63%143.92M42.26%132.49M42.26%132.49M
Retained profit 19.96%1.58B26.33%1.42B20.35%1.61B20.92%1.47B22.34%1.31B18.85%1.12B14.79%1.34B12.98%1.22B6.76%1.07B6.71%943.89M
Less:Treasury stock ----------------------0----------------
Other composite income -83.26%309.08K-62.24%685.94K94.85%1.67M12.51%1.86M194.05%1.85M-16.14%1.82M-60.45%858.06K-21.92%1.65M-49.29%627.84K100.86%2.17M
Ordinary risk reserve funds ----------------------0----------------
Specific reserves --------------2.25M------0----------------
Shareholders equity without minority interests -9.16%2.31B12.66%2.64B16.92%2.83B28.03%2.95B18.62%2.54B16.04%2.34B7.99%2.42B6.69%2.3B0.98%2.14B0.69%2.02B
Minority interests 1,066.91%204.84M11.68%-28.8M-1.78%-27.17M869.47%172.61M-7.08%-21.19M-235.53%-32.61M-250.42%-26.7M-233.87%-22.43M-160.39%-19.78M-5.61%24.06M
Total shareholder equity -0.27%2.52B13.00%2.61B17.09%2.81B36.86%3.12B18.72%2.52B13.07%2.31B5.96%2.4B4.84%2.28B-1.47%2.12B0.61%2.04B
Total liabilityies and equity 28.56%6.9B11.95%6.06B11.10%5.65B27.58%6.42B10.58%5.36B18.85%5.41B8.56%5.08B9.28%5.03B3.50%4.85B2.86%4.55B
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------Lixin Certified Public Accountants (Special General Partnership)------Lixin Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data